Gsm Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -17.88%
- Profit Growth -53.19%
- Ebitda -58.85%
- Net Worth -54.11%
- Total Assets -3.15%
About Gsm Pharma
Gsm Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2011 and has a history of 14 years and one month. Its registered office is in Mohali, Punjab, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suman Devi, Gurpreet Kaur, and Manjeet Kaur serve as directors at the Company.
Company Details
-
Location
Mohali, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232PB2011PTC034563
-
Company No.
034563
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jan 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Gsm Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suman Devi
|
Director | 05-Jan-2011 | Current |
|
Gurpreet Kaur
|
Director | 05-Jan-2011 | Current |
|
Manjeet Kaur
|
Director | 05-Jan-2011 | Current |
Financial Performance of Gsm Pharma.
Gsm Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.88% decrease. The company also saw a substantial fall in profitability, with a 53.19% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gsm Pharma?
In 2023, Gsm Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gsm Pharma?
Unlock and access historical data on people associated with Gsm Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gsm Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gsm Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.